Home » Topics » Disease categories and therapies » Dental

Dental
RSS

CSA-13 exhibits potent bactericidal activity against cariogenic and periodontopathic bacteria

March 13, 2009

Osaka University patents compounds for treatment of periodontitis

Nov. 3, 2008

New agents for periodontitis imparted in recent patent

July 1, 2008

FDA approves Oragenics' IND submission for SMaRT Replacement Therapy for tooth decay

Nov. 7, 2007

Kaken and Sunstar sign agreement for bFGF dental product development

June 22, 2007

1-TDC to begin pre-IND studies

Dec. 13, 2006

Sinclair signs agreement to acquire novel anticaries peptide p1025

Dec. 1, 2006

Effects of magnolol on glucosyltransferase explored

Nov. 15, 2006

Novel agents for dental caries claimed by Queen Mary, University of London

Oct. 31, 2006

NV-101 produces faster return of sensation following dental procedures

Oct. 9, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
Deals and an M&A strengthen end-of-year numbers
BioWorld
Two large deals and an acquisition, totaling about $4.64 billion in all, are helping wrap up what’s turning out to be a strong year. Through the first 11 months...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
Radiopharm Theranostics’ RAD-101 meets brain metastases endpoints
BioWorld
Radiopharm Theranostics Ltd.’s radiotracer RAD-101 met the primary endpoint in 92% of patients in the phase IIb imaging trial in brain metastases, according to...